Tobacco Education and Lung Health Study (TEAL)
Recruiting · NCT06290869 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
E-Referral to the Tobacco QuitlinePhone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention
What this trial is about
Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives 1) To evaluate reach and engagement overall and by subgroup (e.g., race and ethnicity, underinsured, readiness to quit). 2) To conduct an economic analysis to evaluate intervention costs from the health system perspective.
Who can take part
Age range
50 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- eligible for a screening or diagnostic scan,
- USPSTF eligibility criteria (50-80 years old and \>20-pack years);
- currently smoking cigarettes (\>1 in the past 30 days);
- English speaking;
- able to provide meaningful consent.
Exclusion criteria
- prior lung cancer,
- hearing impairment,
- cognitive impairment,
- household member already enrolled.
Where it is running
1 location listed across 1 US state.
- Georgetown University Medical Center - Washington D.C., District of Columbia, United States